Pilot Study of Denileukin Diftitox Plus High-Dose IL-2 for Patients With Metastatic Renal Cancer

NCT00278369 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Kidney Cancer

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: denileukin diftitox

Sponsor

Northwestern University

Collaborators

[object Object]